Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic implications

被引:68
作者
Baritaki, Stavroula [1 ]
Apostolakis, Stavros
Kanellou, Peggy
Dimanche-Boitrel, Marie-Therese
Spandidos, Demetrios A.
Bonavida, Benjamin
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Dept Mol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[2] Univ Crete, Fac Med, Dept Clin Virol, Iraklion, Greece
[3] Univ Rennes 1, Fac Pharm, IF140, UMR620,INSERM, F-35043 Rennes, France
来源
ADVANCES IN CANCER RESEARCH, VOL 98 | 2007年 / 98卷
关键词
D O I
10.1016/S0065-230X(06)98005-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In recent years, significant development and improvement have been observed in the treatment of cancer; however, relapses and recurrences occur frequently and there have not been any current therapies to treat such cancers. Cancers resistant to conventional therapies develop several mechanisms to escape death-inducing stimuli. A poorly understood mechanism is the involvement of the cancer cell plasma membrane composition and architecture and their involvement in regulating drug-inducing stimuli leading to cell death. Although the basic structure of the biological membrane was established 80 years ago, study of the physical properties of lipid bilayers still provides significant information regarding membrane organization and dynamics. Membrane fluidity is probably the most important physicochemical property of cell membranes. Alterations of membrane fluidity can seriously affect functional properties of the cell and induction of apoptotic pathways resulting in cell death. The role of membrane fluidity in the apoptotic process is clearly exemplified as it is seriously disrupted as a result of cell injury. The molecular signaling pathways leading to apoptosis are currently promising areas of research investigation and lead to unravel the underlying molecular mechanisms of tumor cells resistance to apoptotic stimuli and hence the development of new effective therapeutic agents. Recent findings indicate that most anticancer agents induce apoptosis, directly or indirectly, through alterations of tumor cell membrane fluidity. The present chapter summarizes the relationship between alterations of tumor cell membrane fluidity and tumor cell response to a poptotic-inducing Stimuli. Several potential therapeutic applications directed at tumor cell membrane fluidity are proposed. (C) 2007 Elsevier Inc.
引用
收藏
页码:149 / 190
页数:42
相关论文
共 207 条
  • [71] Interferon-induced growth arrest is mediated by membrane structural changes
    Guha, A
    Mason, RP
    Primorac, D
    Konopaske, G
    Miller, J
    Sinha, P
    Tulenko, TN
    Hand, A
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (11) : 701 - 706
  • [72] Raft ceramide in molecular medicine
    Gulbins, E
    Kolesnick, R
    [J]. ONCOGENE, 2003, 22 (45) : 7070 - 7077
  • [73] Structure, organization, and function of glycosphingolipids in membrane
    Hakomori, S
    [J]. CURRENT OPINION IN HEMATOLOGY, 2003, 10 (01) : 16 - 24
  • [74] Hakomori S, 2003, METHOD ENZYMOL, V363, P191
  • [75] GLYCOSPHINGOLIPIDS
    HAKOMORI, S
    [J]. SCIENTIFIC AMERICAN, 1986, 254 (05) : 44 - &
  • [76] DIRECTED CELL-KILLING (APOPTOSIS) IN HUMAN LYMPHOBLASTOID-CELLS INCUBATED IN THE PRESENCE OF FARNESOL - EFFECT OF PHOSPHATIDYLCHOLINE
    HAUG, JS
    GOLDNER, CM
    YAZLOVITSKAYA, EM
    VOZIYAN, PA
    MELNYKOVYCH, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1994, 1223 (01): : 133 - 140
  • [77] Lipids as a target for drugs modulating multidrug resistance of cancer cells
    Hendrich, AB
    Michalak, K
    [J]. CURRENT DRUG TARGETS, 2003, 4 (01) : 23 - 30
  • [78] ABC TRANSPORTERS - FROM MICROORGANISMS TO MAN
    HIGGINS, CF
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1992, 8 : 67 - 113
  • [79] HOMOLYA L, 1993, J BIOL CHEM, V268, P21493
  • [80] Alterations in cell membrane properties caused by perfluorinated compounds
    Hu, WY
    Jones, PD
    DeCoen, W
    King, L
    Fraker, P
    Newsted, J
    Giesy, JP
    [J]. COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2003, 135 (01): : 77 - 88